Skip to main content
Premium Trial:

Request an Annual Quote

House Subcommittee Bill Proposes 7 Percent NIH Budget Increase

NEW YORK — The US House of Representatives Appropriations Committee on Tuesday proposed a fiscal year 2020 spending package that includes a $2.6 billion boost in funding for the National Institutes of Health, as well as budget increases for the US Centers for Disease Control and Prevention and the US Food and Drug Administration.

The legislation would provide the NIH with $41.7 billion for the upcoming fiscal year, a nearly 7 percent increase over the agency's current budget. The bill would specifically allocate $500 million for the All of Us precision medicine program, $500 million for the BRAIN Initiative, $195 million for the Cancer Moonshot research initiative, and $50 million for the Childhood Cancer Data Initiative. 

The CDC, meanwhile, will receive an additional $636 million for a total of $8 billion in fiscal year 2020 funding under the legislation, with the FDA receiving a $91 million increase in discretionary funding to $3.16 billion. 

The full House and US Senate are expected to pass the House appropriations package, sending the legislation to the White House for President Donald Trump's signature, before the federal government's funding runs out on Friday at midnight.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.